PIProBaTo-IINCT07893301
The Impact of Postbiotic Supplementation on Tolerability and Physiological/Metabolic Parameters
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Oct 24, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 1 version: 1 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial completed
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Secondary (18)
Show 13 moreShow less
Arms and interventions
Participants assigned to this arm received one capsule daily containing 100 mg of a postbiotic preparation composed of inactivated Lacticaseibacillus paracasei NPB01 and Lacticaseibacillus rhamnosus GG (1 × 10¹⁰ CFU equivalents) for 12 weeks.
Participants assigned to this arm received one placebo capsule daily without the postbiotic preparation for 12 weeks. The placebo capsules had organoleptic characteristics identical to those of the active supplement to maintain participant blinding.
Dietary supplements: Postbiotic Supplement, Placebo
Sites
1 site in 1 country
- University of Naples Federico IINaples, Naples, Italy